WeSearch
Hub / Tags / Arthritis
TAG · #ARTHRITIS

Arthritis coverage.

Every story in the WeSearch catalog tagged with #arthritis, chronological, with view counts. Subscribe to the per-tag RSS feed to follow this topic in your reader of choice.

14 stories tagged with #arthritis, in publish-time order across the WeSearch catalog. Tag pages update as new stories ingest.

⌘ RSS feed for this tag →   or   search "Arthritis"

RELATED TAGS
#health5#rheumatoid-arthritis2#research2#medical-research2#pharmaceuticals2#clinical-trial1#upadacitinib1#adalimumab1#treatment1#eduardo-mysler1#organizaci-n-medica-de-investigaci-n1#buenos-aires1
LIVE SCIENCE

A cheap arthritis drug shows promise treating RSV in early study

An arthritis drug reduces the amount of RSV in human respiratory cells, but experts say it's too early to say if it will actually treat the common infection.…

8 views ·
#health#medicine#research
THE GUARDIAN

Weight-loss drugs may prevent thousands of knee replacements, study suggests

Patients with knee arthritis who took medications for at least three years at reduced risk of needing surgery Taking weight-loss drugs for at least three years could prevent thousa…

19 views ·
#health#obesity#medical research
MEDSCAPE

Guselkumab Adds PsA Structural Damage Inhibition to Label

Guselkumab is the only IL-23 inhibitor that has been proven to help stop further structural damage in patients with active psoriatic arthritis.…

12 views ·
#health#pharmaceuticals#fda
FORBES — BUSINESS

The Next Frontier For GLP-1 Medications: Potential Therapy For Inflammation

According to a new study, GLP-1s may be potentially effective in reducing chronic inflammation.…

10 views ·
#healthcare#medications#inflammation
MEDSCAPE

Reduced JAK Inhibitor Dosing May Not Compromise RA Outcomes

In patients with rheumatoid arthritis and preserved kidney function, reduced initial doses of JAK inhibitors show 2-year treatment persistence and disease control similar to those …

14 views ·
#rheumatoid arthritis#medical research#pharmaceuticals
MEDSCAPE

What’s in the Axial Spondyloarthritis Treatment Pipeline?

Most available drugs are effective for symptom control and structural protection, but they’re not perfect and new agents are being investigated to help close the treatment gap.…

8 views ·
#health#medicine#research
SCIENCEDAILY

Scientists discover simple way to relieve arthritis pain without pills or surgery

A surprisingly simple walking tweak may offer new hope for millions living with knee osteoarthritis. In a year-long clinical trial, researchers found that slightly changing the ang…

18 views ·
#health#research
SCIENCEDAILY

Popular weight loss drugs like Wegovy may also target arthritis inflammation

Researchers have discovered that the GLP-1 hormone targeted by drugs like Wegovy is present in very low amounts inside the joints of arthritis patients. That finding suggests high-…

20 views ·
#health#medication
SEEKING ALPHA

Roivant: Immunovant's Rheumatoid Arthritis Win Validates The Buy

Roivant (ROIV) Buy case: IMVT-1402 posts strong Phase 2 RA efficacy, backed by $4.3B cash runway—get key catalysts, risks & valuation now.…

15 views ·
#healthcare#pharmaceuticals#investment
STAT

STAT+: Immunovant shares surge on arthritis trial data

Trial results for Lilly's "triple-G" drug, FDA's leadership purge leaves chaos, and more biotech news from The Readout…

12 views ·
MEDSCAPE

Experts on AxSpA-IBD Treatment Weigh In on NSAIDs, Biologics

Experts offer treatment tips for patients with axial spondyloarthritis who also have inflammatory bowel disease.…

11 views ·
#health#medicine#research
YAHOO FINANCE

Can a New Arthritis Drug Make Immunovant the Next Biotech Star?

17 views ·
YAHOO FINANCE

2 Biotech Stocks Are Surging Today Thanks to This Arthritis Drug

16 views ·
MEDSCAPE

Upadacitinib After TNF Inhibitor Failure Improves RA Control

In patients with active RA, switching to upadacitinib after failure of a single TNF inhibitor is more effective in reducing disease activity at 12 weeks than using a second TNF inh…

12 views ·
#rheumatoid arthritis#clinical trial#upadacitinib